Related Experiment Video
Updated: Jul 26, 2026
08:02
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
Published on: March 24, 2023
An animal model for external ear canal inflammation
C G Wright1, K S Pawlowski, P S Roland
1Department of Otolaryngology--Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas 75235-9035, USA.
The Laryngoscope
|July 13, 2000
Summary
This study developed a mouse model for external ear canal (EAC) inflammation using tetradecanoylphorbol acetate (TPA). The model effectively tested anti-inflammatory drugs, showing significant reduction in EAC inflammation with a ciprofloxacin/hydrocortisone suspension.
Area of Science:
- Otolaryngology
- Dermatology
- Pharmacology
Background:
- External ear canal (EAC) diseases require effective anti-inflammatory treatments.
- Developing reliable animal models is crucial for preclinical drug testing.
Purpose of the Study:
- To establish and validate a mouse model of EAC inflammation.
- To assess the efficacy of anti-inflammatory drugs in this model.
Main Methods:
- Topical application of tetradecanoylphorbol acetate (TPA) to induce EAC inflammation in mice.
- Histological and morphometric analyses to characterize inflammation.
- Treatment trial using a ciprofloxacin/hydrocortisone suspension.
Main Results:
- TPA induced significant EAC inflammation, including leukocyte infiltration and tissue thickening.
- The ciprofloxacin/hydrocortisone suspension reduced polymorphonuclear leukocyte counts by 76%.
- Statistically significant reduction in dermal swelling and vascular dilation was observed.
Conclusions:
- TPA-induced EAC inflammation in mice serves as a viable model for evaluating anti-inflammatory drugs.
- This model can aid in the development of treatments for EAC diseases.
